[Scintigraphic monitoring of chondro-protective therapy of finger polyarthritis]

Wien Med Wochenschr. 1990;140(21):526-30.
[Article in German]

Abstract

A pilot study in patients with osteoarthritis of fingers was done to clarify the question, whether abnormal joints in bone scanning can predict degenerative changes in X-rays and if scintigraphy is of help in monitoring therapy with chondroprotective medications. 2 groups of 7 patients with symptomatic osteoarthritis of fingers were treated either with galvanic bath alone or in combination with Rumalon-injections for 6 weeks. After therapy the number of abnormal joints in bone scan and number of tender joints was found reduced in both groups, a decrease of the mean circumference of joints was only seen in the Rumalon-group. After 1 year an increase of degenerative signs in X-rays was demonstrated in both groups. But the number of tender joints was smaller in the Rumalon-group than in controls. For abnormal joints in bone scanning a high positive value was calculated regarding to signs of osteoarthritis in radiographs. But no major information in monitoring the chondroprotective efficacy of the medicament was given by bone scanning.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cartilage, Articular / diagnostic imaging
  • Cartilage, Articular / drug effects
  • Diphosphonates
  • Female
  • Finger Joint* / diagnostic imaging
  • Humans
  • Male
  • Middle Aged
  • Osteoarthritis / diagnostic imaging
  • Osteoarthritis / drug therapy*
  • Prognosis
  • Radionuclide Imaging
  • Technetium
  • Technetium Compounds*
  • Tissue Extracts / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Diphosphonates
  • Technetium Compounds
  • Tissue Extracts
  • Rumalon
  • Technetium
  • technetium Tc 99m diphosphonate